Gregory R. Friberg's Insider Trades & SAST Disclosures

Gregory R. Friberg's most recent trade in Biomarin Pharmaceutical Inc. - Registered Shares was a trade of 6,326 Common Stock done at an average price of $60.4 . Disclosure was reported to the exchange on Feb. 26, 2026.

Share

Note

This is a custom search result for pattern Gregory R. Friberg.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Biomarin pharma Inc - Registered Shares Board Meeting	Gregory R. Friberg	EVP, Chief R&D Officer	Sale of securities on an exchange or to another person at price $ 60.38 per share.	26 Feb 2026	6,326	37,578 (0%)	0%	60.4	381,937	Common Stock
Biomarin pharma Inc - Registered Shares Board Meeting	Gregory R. Friberg	EVP, Chief R&D Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.16 per share.	30 Sep 2025	3,304	43,506 (0%)	0%	54.2	178,945	Common Stock
Biomarin pharma Inc - Registered Shares Board Meeting	Gregory R. Friberg	EVP, Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2025	41,170	41,170	-		-	Stock Option (Right to Buy Common Stock)
Biomarin pharma Inc - Registered Shares Board Meeting	Gregory R. Friberg	EVP, Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2025	17,750	46,810 (0%)	0%		0	Common Stock
Biomarin pharma Inc - Registered Shares Board Meeting	Gregory R. Friberg	EVP, Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2024	49,850	49,850	-		-	Stock Option (Right to Buy Common Stock)
Biomarin pharma Inc - Registered Shares Board Meeting	Gregory R. Friberg	EVP, Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2024	21,190	21,190 (0%)	0%		0	Common Stock
Biomarin pharma Inc - Registered Shares Board Meeting	Gregory R. Friberg	EVP, Chief R&D Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2024	7,870	29,060 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades